Viridian Therapeutics, Inc.\DE (VRDN) Asset Utilization Ratio (2014 - 2026)
Viridian Therapeutics, Inc.\DE's (VRDN) quarterly Asset Utilization Ratio came in at 0.08 in Q1 2026, up 19418.29% year-on-year from N/an in Q1 2025, and down 12.46% quarter-over-quarter from 0.1 in Q4 2025.
Viridian Therapeutics, Inc.\DE (VRDN) Asset Utilization Ratio (2014 - 2026) Analysis & Trends
Viridian Therapeutics, Inc.\DE's Asset Utilization Ratio history runs 13 years deep, the most recent figure standing at 0.08 for Q1 2026.
- On a quarterly basis, Asset Utilization Ratio rose 19418.29% year-over-year to 0.08 in Q1 2026; TTM through Mar 2026 was 0.08, a 19418.29% increase from a year earlier, with the FY2025 full-year figure at 0.09, up 17515.83% from the prior year.
- Asset Utilization Ratio slipped to 0.08 in Q1 2026 per VRDN's latest filing, from 0.1 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 0.12 in Q3 2025 and bottomed at 0.0 in Q4 2024.
- The 5-year median for Asset Utilization Ratio is 0.0 (2023), against an average of 0.02.
- Across the five-year window, Asset Utilization Ratio tumbled 88.11% in 2024 and surged 27344.94% in 2025, its largest moves.
- Year by year, Asset Utilization Ratio stood at 0.0 in 2022, then slumped by 81.06% to 0.0 in 2023, then sank by 47.97% to 0.0 in 2024, then surged by 23959.67% to 0.1 in 2025, then slipped by 12.46% to 0.08 in 2026.
- Per Business Quant, the three latest VRDN Asset Utilization Ratio figures stand at 0.08 (Q1 2026), 0.1 (Q4 2025), and 0.12 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 0.69 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 0.47 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 0.37 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Viridian Therapeutics, Inc.\DE | 631.55 Mn | 631.55 Mn | - | 0.08 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.08 |
| Dec 31, 2025 | 0.10 |
| Sep 30, 2025 | 0.12 |
| Jun 30, 2025 | 0.00 |
| Mar 31, 2025 | 0.00 |
| Dec 31, 2024 | 0.00 |
| Sep 30, 2024 | 0.00 |
| Jun 30, 2024 | 0.00 |
| Mar 31, 2024 | 0.00 |
| Dec 31, 2023 | 0.00 |
| Sep 30, 2023 | 0.00 |
| Jun 30, 2023 | 0.00 |
| Mar 31, 2023 | 0.00 |
| Dec 31, 2022 | 0.00 |
| Sep 30, 2022 | 0.01 |
| Jun 30, 2022 | 0.01 |
| Mar 31, 2022 | 0.01 |
| Dec 31, 2021 | 0.01 |
| Sep 30, 2021 | 0.02 |
| Jun 30, 2021 | 0.02 |